Centre for Systems Biology

The Lilly Centre for Systems Biology (CSB), now part of the Lilly Singapore Centre for Drug Discovery (LSCDD), is a premier research and development hub established by Eli Lilly and Company in Singapore. Founded in 2002, the center focuses on applying systems biology approaches to drug discovery, integrating bioinformatics, genomics, and proteomics to accelerate the identification of novel therapeutic targets and biomarkers. The facility serves as a critical link in Lilly's global R&D network, particularly in the areas of oncology and metabolic diseases. By utilizing advanced computational modeling and high-throughput data analysis, the center aims to improve the predictability and efficiency of the drug development pipeline. Its work supports the transition toward personalized medicine by identifying patient-specific response profiles and optimizing lead compound selection.